The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.

Moniek M Vedder, Esther W de Bekker-Grob, Hans Lilja, Andrew J Vickers, Geert J L H van Leenders, Ewout W Steyerberg, Monique J Roobol

Research output: Contribution to journalArticlepeer-review

64 Citations (SciVal)
134 Downloads (Pure)

Abstract

Prostate-specific antigen (PSA) testing has limited accuracy for the early detection of prostate cancer (PCa).
Original languageEnglish
Pages (from-to)1109-1115
JournalEuropean Urology
Volume66
Issue number6
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Urology and Nephrology

Fingerprint

Dive into the research topics of 'The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.'. Together they form a unique fingerprint.

Cite this